PAA
AGN

Peregrine Asset Advisers’s Allergan plc AGN Stock Holding History

Peregrine Asset Advisers’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,544
Closed -$3.14M – 138
2015
Q1 		$3.14M Sell
10,544
-150
-1% -$42.8K 2.05% 15
2014
Q4 		$2.75M Sell
10,694
-200
-2% -$50K 1.94% 15
2014
Q3 		$2.63M Buy
10,894
+266
+3% +$59.5K 2.16% 13
2014
Q2 		$2.37M Sell
10,628
-11,930
-53% -$2.47M 2.14% 14
2014
Q1 		$4.64M Buy
22,558
+12,030
+114% +$2.38M 3.59% 4
2013
Q4 		$1.77M Buy
10,528
+5,228
+99% +$817K 1.54% 23
2013
Q3 		$763K Sell
5,300
-2,500
-32% -$333K 0.73% 29
2013
Q2 		$985K Buy
+7,800
New +$883K 1.02% 25

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Peregrine Asset Advisers's AGN Position: Q2 2015 in Review

Peregrine Asset Advisers sold out of Allergan plc (AGN) in Q2 2015, closing a stake of 10,544 shares — an estimated $3.14M sold.

Peregrine Asset Advisers first reported a position in AGN in Q2 2013 and held it in 8 quarters. The position peaked at $4.64M in Q1 2014. 1,035 funds tracked by Wall St. Rank hold AGN as of Q2 2015.

  • Peregrine Asset Advisers reported no remaining Allergan plc position as of Q2 2015 after selling out during the quarter.
  • Peregrine Asset Advisers sold 10,544 Allergan plc shares in Q2 2015, an estimated $3.14M.
  • Peregrine Asset Advisers first reported a position in Allergan plc in Q2 2013 and held it in 8 quarters.
  • Peregrine Asset Advisers's Allergan plc position peaked at $4.64M in Q1 2014.
  • 1,035 funds tracked by Wall St. Rank held Allergan plc as of Q2 2015.

Based on Peregrine Asset Advisers's 13F filing for Q2 2015, filed 13 Aug 2015.